Rapid RT-LAMP Assay for Self-Monitoring of Acute or Rebound HIV-1 Infection Using Finger-Prick Whole Blood Sample and RNA Extraction

Award Notice Posted

Solicitation number
PHS-2025-1
Agency
Awarded
to Ai Biosciences, Inc.
Set-aside
Total Small Business

Opportunity facts

Contract number
75N93025C00027 Federal contract award
Place of performance
College Station, Texas 77845, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, awarded contract 75N93025C00027 to AI Biosciences, Inc. for $300,000 to develop a rapid RT-LAMP assay for self-monitoring of acute or rebound HIV-1 infection using finger-prick whole blood samples and RNA extraction. This research and development project is set aside for small businesses and will run for one year from September 1, 2025, through August 31, 2026. The contract focuses on creating diagnostic technology that would enable individuals to self-monitor HIV-1 infection status using a minimally invasive blood sample collection method.

Notice text

Awarded contract 75N93025C00027 to AI BIOSCIENCES, INC. for 300000.00 on 2025-08-29.

Files

File Type Posted
Award Synopsis - AI Biosciences.pdf PDF

Notice history

6 of 10 notices listed here. See the rest on GovTribe.

Similar open opportunities

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors